about
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and ...
Read More
2.81
-0.25
(-8.17%)
835.4K
XNAS Volume
XNAS 14 May, 2026 5:30 PM (EDT)
Board Meeting
The board meeting for Nkarta Inc is scheduled for today, for the purpose of Nkarta Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Nkarta Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..